These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
85 related items for PubMed ID: 18019715
1. A novel anti-cancer substance, MK615, from ume, a variety of Japanese apricot, inhibits growth of hepatocellular carcinoma cells by suppressing Aurora A kinase activity. Okada T, Sawada T, Osawa T, Adachi M, Kubota K. Hepatogastroenterology; 2007 Sep; 54(78):1770-4. PubMed ID: 18019715 [Abstract] [Full Text] [Related]
2. MK615 inhibits pancreatic cancer cell growth by dual inhibition of Aurora A and B kinases. Okada T, Sawada T, Osawa T, Adachi M, Kubota K. World J Gastroenterol; 2008 Mar 07; 14(9):1378-82. PubMed ID: 18322951 [Abstract] [Full Text] [Related]
3. New antineoplastic agent, MK615, from UME (a Variety of) Japanese apricot inhibits growth of breast cancer cells in vitro. Nakagawa A, Sawada T, Okada T, Ohsawa T, Adachi M, Kubota K. Breast J; 2007 Mar 07; 13(1):44-9. PubMed ID: 17214792 [Abstract] [Full Text] [Related]
4. New anti-proliferative agent, MK615, from Japanese apricot "Prunus mume" induces striking autophagy in colon cancer cells in vitro. Mori S, Sawada T, Okada T, Ohsawa T, Adachi M, Keiichi K. World J Gastroenterol; 2007 Dec 28; 13(48):6512-7. PubMed ID: 18161921 [Abstract] [Full Text] [Related]
5. MK615 decreases RAGE expression and inhibits TAGE-induced proliferation in hepatocellular carcinoma cells. Sakuraoka Y, Sawada T, Okada T, Shiraki T, Miura Y, Hiraishi K, Ohsawa T, Adachi M, Takino J, Takeuchi M, Kubota K. World J Gastroenterol; 2010 Nov 14; 16(42):5334-41. PubMed ID: 21072897 [Abstract] [Full Text] [Related]
6. MK615, a Prunus mume Steb. Et Zucc ('Ume') extract, attenuates the growth of A375 melanoma cells by inhibiting the ERK1/2-Id-1 pathway. Tada K, Kawahara K, Matsushita S, Hashiguchi T, Maruyama I, Kanekura T. Phytother Res; 2012 Jun 14; 26(6):833-8. PubMed ID: 22076920 [Abstract] [Full Text] [Related]
7. The selective Aurora B kinase inhibitor AZD1152 as a novel treatment for hepatocellular carcinoma. Aihara A, Tanaka S, Yasen M, Matsumura S, Mitsunori Y, Murakata A, Noguchi N, Kudo A, Nakamura N, Ito K, Arii S. J Hepatol; 2010 Jan 14; 52(1):63-71. PubMed ID: 19913935 [Abstract] [Full Text] [Related]
8. Antitumor effect of Japanese apricot extract (MK615) on human cancer cells in vitro and in vivo through a reactive oxygen species-dependent mechanism. Hattori M, Kawakami K, Akimoto M, Takenaga K, Suzumiya J, Honma Y. Tumori; 2013 Jan 14; 99(2):239-48. PubMed ID: 23748821 [Abstract] [Full Text] [Related]
9. Inhibitory effects of evodiamine on the growth of human prostate cancer cell line LNCaP. Kan SF, Huang WJ, Lin LC, Wang PS. Int J Cancer; 2004 Jul 10; 110(5):641-51. PubMed ID: 15146552 [Abstract] [Full Text] [Related]
10. Advanced hepatocellular carcinoma responds to MK615, a compound extract from the Japanese apricot "Prunus mume". Hoshino T, Takagi H, Naganuma A, Koitabashi E, Uehara S, Sakamoto N, Kudo T, Sato K, Kakizaki S. World J Hepatol; 2013 Oct 27; 5(10):596-600. PubMed ID: 24179621 [Abstract] [Full Text] [Related]
11. Sustained antitumor activity by co-targeting mTOR and the microtubule with temsirolimus/vinblastine combination in hepatocellular carcinoma. Zhou Q, Lui VW, Lau CP, Cheng SH, Ng MH, Cai Y, Chan SL, Yeo W. Biochem Pharmacol; 2012 May 01; 83(9):1146-58. PubMed ID: 22285225 [Abstract] [Full Text] [Related]
12. MK615 Suppresses Hypoxia Tolerance by Up-regulation of E-cadherin in Colorectal Cancer Cells With Mutant KRAS. Nishi K, Tsunoda T, Uchida Y, Sueta T, Sawatsubashi M, Yamano T, Hashiguchi Y, Swain A, Shirasawa S, Sakata T. Anticancer Res; 2020 Aug 01; 40(8):4687-4694. PubMed ID: 32727793 [Abstract] [Full Text] [Related]
13. Specific COX-2 inhibitor, meloxicam, suppresses proliferation and induces apoptosis in human HepG2 hepatocellular carcinoma cells. Li J, Chen X, Dong X, Xu Z, Jiang H, Sun X. J Gastroenterol Hepatol; 2006 Dec 01; 21(12):1814-20. PubMed ID: 17074019 [Abstract] [Full Text] [Related]
14. Isocorydine inhibits cell proliferation in hepatocellular carcinoma cell lines by inducing G2/m cell cycle arrest and apoptosis. Sun H, Hou H, Lu P, Zhang L, Zhao F, Ge C, Wang T, Yao M, Li J. PLoS One; 2012 Dec 01; 7(5):e36808. PubMed ID: 22623962 [Abstract] [Full Text] [Related]
15. Butein suppresses hepatocellular carcinoma growth via modulating Aurora B kinase activity. Zhou Y, Li M, Yu X, Liu T, Li T, Zhou L, Liu W, Li W, Gao F. Int J Biol Sci; 2018 Dec 01; 14(11):1521-1534. PubMed ID: 30263005 [Abstract] [Full Text] [Related]
16. MK615: a new therapeutic approach for the treatment of oral disease. Morimoto-Yamashita Y, Matsuo M, Komatsuzawa H, Kawahara K, Kikuchi K, Torii M, Tokuda M. Med Hypotheses; 2011 Aug 01; 77(2):258-60. PubMed ID: 21565449 [Abstract] [Full Text] [Related]
17. The Aurora kinase inhibitor VE-465 has anticancer effects in pre-clinical studies of human hepatocellular carcinoma. Lin ZZ, Hsu HC, Hsu CH, Yeh PY, Huang CY, Huang YF, Chen TJ, Kuo SH, Hsu C, Hu FC, Jeng YM, Chung Y, Cheng AL. J Hepatol; 2009 Mar 01; 50(3):518-27. PubMed ID: 19155085 [Abstract] [Full Text] [Related]
18. Antitumor effects of ginsenoside Rg3 on human hepatocellular carcinoma cells. Zhang C, Liu L, Yu Y, Chen B, Tang C, Li X. Mol Med Rep; 2012 May 01; 5(5):1295-8. PubMed ID: 22366885 [Abstract] [Full Text] [Related]
19. A novel therapeutic combination sequentially targeting aurora B and Bcl-xL in hepatocellular carcinoma. Matsunaga H, Tanaka S, Aihara A, Ogawa K, Matsumura S, Ban D, Ochiai T, Irie T, Kudo A, Nakamura N, Arii S, Tanabe M. Ann Surg Oncol; 2015 Sep 01; 22(9):3079-86. PubMed ID: 25524010 [Abstract] [Full Text] [Related]
20. Anticancer properties of Prunus mume extracts (Chinese plum, Japanese apricot). Bailly C. J Ethnopharmacol; 2020 Jan 10; 246():112215. PubMed ID: 31491438 [Abstract] [Full Text] [Related] Page: [Next] [New Search]